PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Drug Research, CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.\', \'School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, China.\', \'Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.\', \'State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.\', \'University of Chinese Academy of Sciences, Beijing 100049, China.\', \'College of Pharmacy, Nanjing University of Chinese Medicine, Qixia District, Nanjing 210023, China.\', \'National Chengdu Center for Safety Evaluation of Drugs, Westchina Hospital of Sichuan University, High-Tech Development Zone, Chengdu, Sichuan 610041, China.\', \'State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Response, College of Life Sciences, College of Pharmacy, Nankai University, Tianjin 300353, China.\', \'State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China. hliu@simm.ac.cn yanght@shanghaitech.edu.cn zhangleike@wh.iov.cn ycxu@simm.ac.cn.\', \'State Key Laboratory of Drug Research, CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. hliu@simm.ac.cn yanght@shanghaitech.edu.cn zhangleike@wh.iov.cn ycxu@simm.ac.cn.\', \'Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China. hliu@simm.ac.cn yanght@shanghaitech.edu.cn zhangleike@wh.iov.cn ycxu@simm.ac.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1126/science.abb4489
?:hasPublicationType
?:journal
  • Science (New York, N.Y.)
is ?:pmid of
?:pmid
?:pmid
  • 32321856
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32321856>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32321856>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all